Human papillomaviruses and non-melanoma skin cancer

Seminars in Oncology

Volumn 42, Issue 2, 2015, Pages 284-290

  McLaughlin Drubin, Margaret E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET RADIATION; VERRUCA VULGARIS; WART VIRUS; BASAL CELL CARCINOMA; PAPILLOMAVIRUS INFECTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 84926295849     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.12.032     Document Type: Review

References (93)

1. M. Alam, and D. Ratner Cutaneous squamous-cell carcinoma N Engl J Med 344 13 2001 975 983
2. S. Euvrard, J. Kanitakis, and A. Claudy Skin cancers after organ transplantation N Engl J Med 348 17 2003 1681 1691
3. C. Ulrich, J. Kanitakis, E. Stockfleth, and S. Euvrard Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 8 11 2008 2192 2198
4. K. Andersson, T. Waterboer, and R. Kirnbauer Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions Cancer Epidemiol Biomarkers Prev 17 1 2008 189 195
5. D. Casabonne, K.M. Michael, and T. Waterboer A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition Int J Cancer 121 8 2007 1862 1868
6. M.C. Feltkamp, R. Broer, and F.M. di Summa Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer Cancer Res 63 10 2003 2695 2700
7. M.R. Karagas, H.H. Nelson, and P. Sehr Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin J Natl Cancer Inst 98 6 2006 389 395
8. M.R. Karagas, T. Waterboer, and Z. Li Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study BMJ 341 2010 c2986
9. L. Struijk, L. Hall, and E. van der Meijden Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 15 3 2006 529 535
10. M.E. McLaughlin-Drubin, and K. Munger Oncogenic activities of human papillomaviruses Virus Res 143 2 2009 195 208
11. Lewandowski F, Lutz FW. Ein fall einer bisher noch nicht beschriebenen Hauterkrankung (Epidermodysplasia verrusiformis). Arch Derrm Syph. 1922;141:193-203.
12. S. Jablonska, J. Dabrowski, and K. Jakubowicz Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis Cancer Res 32 3 1972 583 589
13. S. Jablonska Epidermodysplasis verruciformis 1991 Saunders Philadelphia, PA
14. W. Lutz A propos de l'épidermodysplasie verruciforme Dermatologica 92 4 1946 199 217
15. S. Jablonska, and I. Formas Weitere positive Ergebnisse mit Auto- und Heteroinokulation beiEpidermodysplasia verruciformis Lewandowsky-Lutz Dermatologica 118 1959 86 93
16. H. Pfister Human papillomavirus and skin cancer J Natl Cancer Inst Monogr 31 2003 52 56
17. S. Majewski, and S. Jablonska Human papillomavirus-associated tumors of the skin and mucosa J Am Acad Dermatol 36 5 Pt 1 1997 659 685
18. V. Bouvard, R. Baan, and K. Straif A review of human carcinogens - part B: biological agents Lancet Oncol 10 4 2009 321 322
19. A. Gewirtzman, B. Bartlett, and S. Tyring Epidermodysplasia verruciformis and human papilloma virus Curr Opin Infect Dis 21 2 2008 141 146
20. S. Jablonska, and G. Orth Epidermodysplasia verruciformis Clin Dermatol 3 4 1985 83 96
21. S. Majewski, S. Jablonska, and G. Orth Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression Clin Dermatol 15 1997 321 334
22. M. Lutzner An autosomal recessive disease characterized by viral warts and skin cancer: a model for viral oncogenesis Bull Cancer 65 1978 169 182
23. S. Jablonska, G. Orth, and M. Jarzabek-Chorzelska Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis Dermatologica 158 5 1979 309 327
24. W. Glinski, S. Jablonska, and A. Langner Cell-mediated immunity in epidermodysplasia verruciformis Dermatologica 153 4 1976 218 227
25. S.E. Prawer, F. Pass, and J.C. Vance Depressed immune function in epidermodysplasia verruciformis Arch Dermatol 113 4 1977 495 499
26. S. Majewski, N. Hunzelmann, and R. Nischt TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis J Invest Dermatol 97 5 1991 862 867
27. N. Ramoz, L.A. Rueda, B. Bouadjar, M. Favre, and G. Orth A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus J Invest Dermatol 112 3 1999 259 263
28. N. Ramoz, L.A. Rueda, B. Bouadjar, L.S. Montoya, G. Orth, and M. Favre Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis Nat Genet 32 4 2002 579 581
29. N. Ramoz, A. Taieb, and L.A. Rueda Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25 J Invest Dermatol 114 2000 1148 1153
30. R.D. Palmiter, and S.D. Findley Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc EMBO J 14 4 1995 639 649
31. M. Lazarczyk, C. Pons, J.A. Mendoza, P. Cassonnet, Y. Jacob, and M. Favre Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses J Exp Med 205 1 2008 35 42
32. G. Orth Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses Semin Immunol 18 6 2006 362 374
33. B. Akgul, O. Kose, and M. Safali A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations J Dermatol Sci 46 3 2007 214 216
34. G.W. Dandie, G.J. Clydesdale, I. Jacobs, and H.K. Muller Effects of UV on the migration and function of epidermal antigen presenting cells Mutat Res 422 1 1998 147 154
35. M.C. Dieu-Nosjean, C. Massacrier, and B. Homey Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors J Exp Med 192 5 2000 705 718
36. M. Le Borgne, N. Etchart, and A. Goubier Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+T cell crosspriming in vivo Immunity 24 2 2006 191 201
37. A.S. Charbonnier, N. Kohrgruber, E. Kriehuber, G. Stingl, A. Rot, and D. Maurer Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells J Exp Med 190 12 1999 1755 1768
38. T. Sperling, M. Oldak, and B. Walch-Ruckheim Human papillomavirus type 8 interferes with a novel C/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration PLoS Pathog 8 7 2012 e1002833
39. S. Euvrard, J. Kanitakis, and S. Bosshard No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation Transplantation 73 2 2002 297 299
40. J.N. Bouwes Bavinck, M. Feltkamp, L. Struijk, and J. ter Schegget Human papillomavirus infection and skin cancer risk in organ transplant recipients J Invest Dermatol Symp Proc 6 3 2001 207 211
41. I. Nindl, and F. Rosl Molecular concepts of virus infections causing skin cancer in organ transplant recipients Am J Transplant 8 11 2008 2199 2204
42. L.A. Stark, M.J. Arends, and K.M. McLaren Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion Br J Cancer 69 2 1994 222 229
43. S.A. Birkeland, H.H. Storm, and L.U. Lamm Cancer risk after renal transplantation in the Nordic countries. 1964-1986 Int J Cancer 60 2 1995 183 189
44. K. Blessing, K.M. McLaren, and E.C. Benton Histopathology of skin lesions in renal allograft recipients - an assessment of viral features and dysplasia Histopathology 14 2 1989 129 139
45. S. Euvrard, Y. Chardonnet, and C. Pouteil-Noble Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients Cancer 72 7 1993 2198 2206
46. V. Shamanin, M. Glover, and C. Rausch Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients Cancer Res 54 1994 4610 4613
47. V. Shamanin, H. Zurhausen, and D. Lavergne Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients J Nat Cancer Inst 88 12 1996 802 811
48. C.A. Harwood, T. Surentheran, and J.M. McGregor Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals J Med Virol 61 3 2000 289 297
49. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses IARC Monogr Eval Carcinog Risks Hum 90 2007 1 636
50. H. zur Hausen Papillomaviruses in the causation of human cancers - a brief historical account Virology 384 2 2009 260 265
51. B. Aldabagh, J.G. Angeles, A.R. Cardones, and S.T. Arron Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg 39 2013 1 23
52. G. Astori, D. Lavergne, and C. Benton Human papillomaviruses are commonly found in normal skin of immunocompetent hosts J Invest Dermatol 110 5 1998 752 755
53. S.F. Farzan, T. Waterboer, and J. Gui Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study Int J Cancer 133 7 2013 1713 1720
54. M.R. Iannacone, T. Gheit, and T. Waterboer Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin Cancer Epidemiol Biomarkers Prev 21 8 2012 1303 1313
55. J.N. Bouwes Bavinck, R.E. Neale, and D. Abeni Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma Cancer Res 70 23 2010 9777 9786
56. O. Forslund, T. Iftner, and K. Ersson Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma J Infect Dis 196 6 2007 876 883
57. T. Waterboer, D. Abeni, and F. Sampogna Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin Br J Dermatol 159 2 2008 457 459
58. M.R. Iannacone, T. Gheit, and H. Pfister Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma Int J Cancer 134 9 2014 2231 2244
59. M.R. Iannacone, T. Gheit, and T. Waterboer Case-control study of cutaneous human papillomavirus infection in basal cell carcinoma of the skin J Invest Dermatol 133 6 2013 1512 1520
60. N. Vasiljevic, K. Hazard, J. Dillner, and O. Forslund Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis J Gen Virol 89 Pt 10 2008 2467 2474
61. S.J. Weissenborn, I. Nindl, and K. Purdie Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers J Invest Dermatol 125 1 2005 93 97
62. S.T. Arron, J.G. Ruby, E. Dybbro, D. Ganem, and J.L. Derisi Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma J Invest Dermatol 131 8 2011 1745 1753
63. T. Ganzenmueller, Y. Yakushko, J. Kluba, C. Henke-Gendo, R. Gutzmer, and T.F. Schulz Next-generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma Int J Cancer 131 7 2012 E1173 E1179
64. P.J. Snijders, C.J. Hogewoning, and A.T. Hesselink Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology Int J Cancer 119 5 2006 1102 1107
65. I.D. Schaper, G.P. Marcuzzi, S.J. Weissenborn, H.U. Kasper, V. Dries, and N. Smyth Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8 Cancer Res 65 4 2005 1394 1400
66. M. De Andrea, M. Ritta, and M.M. Landini Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice Cancer Res 70 20 2010 7938 7948
67. N. Schroer, J. Pahne, B. Walch, C. Wickenhauser, and S. Smola Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression Cancer Res 71 1 2011 87 97
68. G.P. Marcuzzi, M. Hufbauer, H.U. Kasper, S.J. Weissenborn, S. Smola, and H. Pfister Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding J Gen Virol 90 Pt 12 2009 2855 2864
69. R. Pfefferle, G.P. Marcuzzi, and B. Akgul The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice J Invest Dermatol 128 9 2008 2310 2315
70. W. Dong, U. Kloz, and R. Accardi Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38 J Virol 79 23 2005 14899 14908
71. A. Michel, A. Kopp-Schneider, H. Zentgraf, A.D. Gruber, and E.M. de Villiers E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice J Virol 80 22 2006 11153 11164
72. D. Viarisio, K. Mueller-Decker, and U. Kloz E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice PLoS Pathog 7 7 2011 e1002125
73. N. Dyson, P.M. Howley, K. Münger, and E. Harlow The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
74. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
75. E.A. White, M.E. Sowa, and M.J. Tan Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses Proc Natl Acad Sci U S A 109 5 2012 E260 E267
76. S. Caldeira, I. Zehbe, and R. Accardi The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties J Virol 77 3 2003 2195 2206
77. O. Rozenblatt-Rosen, R.C. Deo, and M. Padi Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins Nature 487 7408 2012 491 495
78. E.A. White, R.E. Kramer, M.J. Tan, S.D. Hayes, J.W. Harper, and P.M. Howley Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity J Virol 86 24 2012 13174 13186
79. M. Elbel, S. Carl, S. Spaderna, and T. Iftner A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential Virology 239 1 1997 132 149
80. G. Steger, and H. Pfister In vitro expressed HPV 8 E6 protein does not bind p53 Arch Virol 125 1992 355 360
81. I. Cornet, V. Bouvard, and M.S. Campo Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types J Virol 86 4 2012 2366 2370
82. R. Accardi, W. Dong, and A. Smet Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73 EMBO Rep 7 3 2006 334 340
83. S. Jackson, and A. Storey E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage Oncogene 19 4 2000 592 598
84. B. Akgul, W. Lemme, R. Garcia-Escudero, A. Storey, and H.J. Pfister UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes Arch Virol 150 1 2005 145 151
85. M.P. Underbrink, H.L. Howie, K.M. Bedard, J.I. Koop, and D.A. Galloway E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation J Virol 82 21 2008 10408 10417
86. M. Simmonds, and A. Storey Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis Int J Cancer 123 10 2008 2260 2266
87. H.L. Howie, J.I. Koop, and J. Weese Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association PLoS Pathog 7 8 2011 e1002211
88. N.A. Wallace, K. Robinson, H.L. Howie, and D.A. Galloway HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage PLoS Pathog 8 7 2012 e1002807
89. N. Brimer, C. Lyons, A.E. Wallberg, and S.B. Vande Pol Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling Oncogene 31 43 2012 4639 4646
90. M.J. Tan, E.A. White, M.E. Sowa, J.W. Harper, J.C. Aster, and P.M. Howley Cutaneous beta-human papillomavirus E6 proteins bind mastermind-like coactivators and repress Notch signaling Proc Natl Acad Sci U S A 109 23 2012 E1473 E1480
91. J.M. Meyers, J.M. Spangle, and K. Munger The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation J Virol 87 8 2013 4762 4767
92. M. Nicolas, A. Wolfer, and K. Raj Notch1 functions as a tumor suppressor in mouse skin Nat Genet 33 3 2003 416 421
93. J.A. Mendoza, Y. Jacob, P. Cassonnet, and M. Favre Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3 J Virol 80 24 2006 12420 12424